𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Aggravation by prostaglandin E2 of interleukin-6-dependent insulin resistance in hepatocytes

✍ Scribed by Janin Henkel; Frank Neuschäfer-Rube; Andrea Pathe-Neuschäfer-Rube; Gerhard P. Püschel


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
451 KB
Volume
50
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


Hepatic insulin resistance is a major contributor to fasting hyperglycemia in patients with metabolic syndrome and type 2 diabetes. Circumstantial evidence suggests that cyclooxygenase products in addition to cytokines might contribute to insulin resistance. However, direct evidence for a role of prostaglandins in the development of hepatic insulin resistance is lacking. Therefore, the impact of prostaglandin E(2) (PGE(2)) alone and in combination with interleukin-6 (IL-6) on insulin signaling was studied in primary hepatocyte cultures. Rat hepatocytes were incubated with IL-6 and/or PGE(2) and subsequently with insulin. Glycogen synthesis was monitored by radiochemical analysis; the activation state of proteins of the insulin receptor signal chain was analyzed by western blot with phosphospecific antibodies. In hepatocytes, insulin-stimulated glycogen synthesis and insulin-dependent phosphorylation of Akt-kinase were attenuated synergistically by prior incubation with IL-6 and/or PGE(2) while insulin receptor autophosphorylation was barely affected. IL-6 but not PGE(2) induced suppressors of cytokine signaling (SOCS3). PGE(2) but not IL-6 activated extracellular signal-regulated kinase 1/2 (ERK1/2) persistently. Inhibition of ERK1/2 activation by PD98059 abolished the PGE(2)-dependent but not the IL-6-dependent attenuation of insulin signaling. In HepG2 cells expressing a recombinant EP3-receptor, PGE(2) pre-incubation activated ERK1/2, caused a serine phosphorylation of insulin receptor substrate 1 (IRS1), and reduced the insulin-dependent Akt-phosphorylation.

Conclusion:

Pge(2) might contribute to hepatic insulin resistance via an ep3-receptor-dependent erk1/2 activation resulting in a serine phosphorylation of insulin receptor substrate, thereby preventing an insulin-dependent activation of akt and glycogen synthesis. since different molecular mechanisms appear to be employed, pge(2) may synergize with il-6, which interrupted the insulin receptor signal chain, principally by an induction of socs, namely socs3.


📜 SIMILAR VOLUMES


Regulation by prostaglandin E2 of interl
✍ Susan Barrera; Joyce Lai; Claudio Fiocchi; James K. Roche 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 894 KB

Regulation of immune cell activation in lymphocyte-bearing human tissues is a pivotal host function, and metabolites of arachidonic acid (prostaglandin E, in particular) have been reported to serve this function at non-mucosal sites. However, it is unknown whether prostaglandin E2 is immunoregulator

Estrogen receptor–related receptor α reg
✍ Edith Bonnelye; Pascal Reboul; Nicolas Duval; Marco Cardelli; Jane E. Aubin 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB

## Abstract ## Objective We reported previously that the orphan nuclear receptor, estrogen receptor–related receptor α (ERRα), is expressed in articular chondrocytes and is dysregulated in a mouse model of inflammatory arthritis. The aim of this study, therefore, was to determine whether ERRα is a

Inhibition by recombinant human interleu
✍ Bruno Christ Phd.; Annegret Nath; Peter C. Heinrich; Kurt Jungermann 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 811 KB

The influence of recombinant human interleukin-6, the major mediator of the inflammatory response in liver, on the glucagon-and insulin-dependent induction of the phosphoenolpyruvate carboqkinase and glucokinase gene, respectively, was monitored on the level of gene transcription, mRNA abundance and